NCT00027053

Trazodone for Sleep Disturbance in Early Alcohol Recovery

Trazodone for Sleep Disturbance - Early Alcohol Recovery

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 173 (actual)
• Sponsor: Rhode Island Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)

Conditions

• Alcoholism

Interventions

Type	Name	Description
DRUG	Trazodone	50 to 150 mg qhs
DRUG	Placebo

Timeline

• Start date: 2002-06-01
• Primary completion: 2006-01-01
• Completion: 2006-06-01
• First posted: 2001-11-20
• Last updated: 2010-05-13

Locations

1 site across 1 country: United States